Closure of USFDA inspection at Zydus' oncology injectable plant at Ahmedabad

The US, Food and Drug Administration (USFDA) conducted a GMP follow-up inspection at the company's oncology injectable site situated at SEZ 1, near Matoda, Ahmedabad. The inspection was conducted from 9th of June to 18th of June 2025.

The inspection is closed with 2 observations and none of them were related to data integrity. The Company will closely work with the USFDA to address and respond to the observations in an expeditious manner.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 957.80 as compared to the previous close of Rs. 958.90. The total number of shares traded during the day was 67026 in over 3567 trades.

The stock hit an intraday high of Rs. 965.00 and intraday low of 949.00. The net turnover during the day was Rs. 64241132.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals USFDA Insepction Closure OncologyInjectable Ahmedabad